Stock comparison
Pro Medicus Limited
PME.AX$16.79BHealthcare Market cap, Sector
STERIS
STE$22.53BHealthcare Market cap, Sector
Overall winner
Pro Medicus Limited
PME.AX 70 STE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
PME.AX7wins
0winsSTE
78B
D47
90A
C62
98A
D52
100A
D46
84B
F29
91A
F36
96A
F42
Side-by-side metrics
| Metric | PME.AX | STE |
|---|---|---|
| Market cap | $16.79B | $22.53B Winner |
| P/E (TTM) | 147.6x | 25.3x Winner |
| EV/EBIT | 106.8x | 17.7x Winner |
| ROIC (TTM) | Winner: 42.56% | 8.51% |
| Gross margin | Winner: 99.85% | 44.25% |
| Net margin | Winner: 54.12% | 13.18% |
| Revenue CAGR 5y | Winner: 31.61% | 8.88% |
| EPS CAGR 5y | Winner: 37.34% | 33.45% |
| Debt / Equity | Winner: 0.0x | 0.0x |
| Dividend yield | - | 1.22% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
PME.AX leads on
- ROIC (TTM)42.56%vs 8.51%+80%
- Net margin54.12%vs 13.18%+76%
- Revenue CAGR 5y31.61%vs 8.88%+72%
- Gross margin99.85%vs 44.25%+56%
STE leads on
- EV/EBIT17.7xvs 106.8x+83%
- P/E (TTM)25.3xvs 147.6x+83%
- Market cap$22.53Bvs $16.79B+25%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.